T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: Relevance to HTLV-I-induced neurological disease

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2718-2727

  Giraudon, Pascale ^a   Szymocha, Raphaël ^a   Buart, Stéphanie ^a   Bernard, Arlette ^a   Cartier, Luis ^b   Belin, Marie Françoise ^a   Akaoka, Hideo ^a  

^a INSERM   (France)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; FIBRONECTIN; GELATINASE B; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LYMPHOTOXIN; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPATHOGENESIS; INFLAMMATION; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0034161684     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2718     Document Type: Article

References (62)

1. Summers, B. A., H. A. Greisen, and M. J. Appel. 1978. Possible initiation of viral encephalomyelitis in dogs by migrating lymphocytes infected with distemper virus. Lancet 2:187.
2. Katsetos, C. D., J. E. Fincke, A. Legido, H. W. Lischner, J. P. de Chadarevian, E. M. Kaye, C. D. Platsoucas, and E. L. Oleszak. 1999. Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin. Diagn. Lab. Immunol. 6:105.
3. Hausmann, S., and K. W. Wucherpfennig. 1997. Activation of autoreactive T cells by peptides from human pathogens. Curr. Opin. Immunol. 9:831.
4. Hickey, W. F. 1999. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11:125.
5. Brown, M. J., and S. Shaw. 1999. T-cell activation: interplay at the interface. Curr. Biol. 9:R26.
6. + T cells. Ann. Neurol. 38:723.
7. 4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA 96:6896.
8. Archelos, J. J., S. C. Previtali, and H. P. Hartung. 1999. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci. 22:30.
9. Xiao, B. G., and H. Link. 1998. Immune regulation within the central nervous system. J. Neurol. Sci. 157:1.
10. McGeer, E. G., and P. L. McGeer. 1997. The role of the immune system in neurodegenerative disorders. Mov. Disord. 12:855.
11. Eddleston, M., and L. Mucke. 1993. Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience 54:15.
12. Poser, C. 1992. Multiple sclerosis - observations and reflections: a personal memoir. J. Neurol. Sci. 107:127.
13. Cuzner, M. L., D. Gveric, C. Strand, A. J. Loughlin, L. Paemen, G. Opdenakker, and J. Newcombe. 1996. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55:1194.
14. Gessain, A., F. Barin, J. Vernant, O. Gout, L. Maurs, A. Calender, and G. de Thè. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407.
15. Buckle, G. J., D. A. Hafler, and P. Hollsberg. 1996. HTLV-I-induced T-cell activation. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S107.
16. Umehara, F., S. Izumo, A. Ronquillo, K. Matsumuro, E. Sato, and M. Osame. 1994. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 53:72.
17. Galis, Z. S., M. Muszynski, G. K. Sukhova, E. Simon-Morrissey, and P. Libby. 1995. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. NY Acad. Sci. 748:501.
18. Martel-Pelletier, J., R. McCollum, N. Fujimoto, K. Obata, J. M. Cloutier, and J. P. Pelletier. 1994. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest. 70:807.
19. Giraudon, P., A. Bernard, C. Malcus, N. Dufay, C. Desgranges, and M. Belin. 1995. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells. J. Neuropathol. Exp. Neurol. 54:165.
20. Giraudon, P., N. Thomasset, A. Bernard, B. Verrier, and M. F. Belin. 1995. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. Eur. J. Neurosci. 7:841.
21. Giraudon, P., S. Buart, A. Bernard, N. Thomasset, and M. F. Belin. 1996. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog. Neurobiol. 49:169.
22. Giraudon, P., J. C. Vernant, C. Confavreux, M. F. Belin, and C. Desgranges. 1998. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-I infected patients with tropical spastic paraparesis. Neurology 50:1920.
23. Jennings, M. T., D. L. Jennings, S. A. Ebrahim, M. D. Johnson, C. Turc-Carel, T. Philip, I. Philip, C. Lapras, and J. R. Shapiro. 1992. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas. Eur. J. Cancer 28A:762.
24. Popovic, M., G. Lange-Wantzin, P. Sarin, D. Mann, and R. Gallo. 1983. Transformation of human umbilical cord blood T cells by human T-cell leukemia/ lymphoma virus. Proc. Natl. Acad. Sci. USA 80:5402.
25. Salahuddin, S. Z., P. D. Markham, F. Wong-Staal, G. Franchini, V. S. Kalyanaraman, and R. C. Gallo. 1983. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129:51.
26. Jeang, K. T., D. Derse, M. Matocha, and O. Sharma. 1997. Expression status of Tax protein in human T-cell leukemia virus type I-transformed MT4 cells: recall of MT4 cells distributed by the NIH AIDS Research and Reference Reagent Program. J. Virol. 71:6277.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
28. Mohler, K. M., and L. D. Butler. 1991. Quantitation of cytokine mRNA levels utilizing the reverse transcriptase-polymerase chain reaction following primary antigen-specific sensitization in vivo. I. Verification of linearity, reproducibility and specificity. Mol. Immunol. 28:437.
29. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
30. Apodaca, G., J. T. Rutka, K. Bouhana, M. E. Berens, J. R. Giblin, M. L. Rosenblum, J. H. McKerrow, and M. J. Banda. 1990. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50:2322.
31. Edwards, D. R., P. P. Beaudry, T. D. Laing, V. Kowal, K. J. Leco, P. A. Leco, and M. S. Lim. 1996. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int. J. Obes. Relat. Metab. Disord. 20(Suppl. 3):S9.
32. Basbaum, C. B., and Z. Werb. 1996. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8:731.
33. 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129:867.
34. Yokoo, T., and M. Kitamura. 1996. Dual regulation of IL-1 β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am. J. Physiol. 270:F123.
35. Yoshida, T., and M. Takeuchi. 1991. Expression of fibronectin and laminin by different types of mouse glial cells cultured in a serum-free medium. Cytotechnology 7:187.
36. Werb, Z., and J. R. Chin. 1998. Extracellular matrix remodeling during morphogenesis. Ann. NY Acad. Sci. 857:110.
37. Muir, D. 1994. Metalloproteinase-dependent neunte outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp. Cell Res. 210:243.
38. Sheffield, J. B., V. Krasnopolsky, and E. Dehlinger. 1994. Inhibition of retinal growth cone activity by specific metalloproteinase inhibitors in vitro. Dev. Dyn. 200:79.
39. Vaillant, C., M. Didier-Bazes, A. Hutter, M. F. Belin, and N. Thomasset. 1999. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J. Neurosci. 19:4994.
40. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439.
41. Goetzl, E. J., M. J. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. J. Immunol. 156:1.
42. Johnatty, R. N., D. D. Taub, S. P. Reeder, S. M. Turcovski-Corrales, D. W. Cottam, T. J. Stephenson, and R. C. Rees. 1997. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158:2327.
43. Xia, M., D. Leppert, S. L. Hauser, S. P. Sreedharan, P. J. Nelson, A. M. Krensky, and E. J. Goetzl. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156:160.
44. Miltenburg, A. M., S. Lacraz, H. G. Welgus, and J. M. Dayer. 1995. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154:2655.
45. Aoudjit, F., E. F. Potworowski, and Y. St-Pierre. 1998. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J. Immunol. 160:2967.
46. Chandler, S., K. M. Miller, J. M. Clements, J. Lury, D. Corkill, D. C. Anthony, S. E. Adams, and A. J. Gearing. 1997. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72:155.
47. Dayer, J. M., P. Isler, and L. P. Nicod. 1993. Adhesion molecules and cytokine production. Am. Rev. Respir. Dis. 148:S70.
48. 1 integrins on HTLV-I-infected lymphocytes. Virology 197:778.
49. Rosenberg, G. A., J. E. Dencoff, N. Correa, Jr., M. Reiners, and C. C. Ford. 1996. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46:1626.
50. Pagerstecher, A., A. K. Stalder, C. L. Kincaid, S. D. Shapiro, and I. L. Campbell. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152:729.
51. Itoh, Y., and H. Nagase. 1995. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J. Biol. Chem. 270:16518.
52. Andreu, T., T. Beckers, E. Thoenes, P. Hilgard, and H. von Melchner. 1998. Gene trapping identifies inhibitors of oncogenic transformation: the tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type I α2 (COL1A2) are epidermal growth factor-regulated growth repressors. J. Biol. Chem. 273:13848.
53. Baker, A. H., A. B. Zaltsman, S. J. George, and A. C. Newby. 1998. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis. J. Clin. Invest. 101:1478.
54. Umehara, P., Y. Okada, N. Fujimoto, M. Abe, S. Izumo, and M. Osame. 1998. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 57:839.
55. Sobel, R. A., and M. E. Mitchell. 1989. Fibronectin in multiple sclerosis lesions. Am. J. Pathol. 135:161.
56. Raine, C. 1991. Multiple sclerosis: a pivotal role for the T cell in lesion development. Neuropathol. Appl. Neurobiol. 17:265.
57. Gijbels, K., P. Proost, S. Masure, H. Carton, A. Billiau, and G. Opdenakker. 1993. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J. Neurosci. Res. 36:432.
58. Proost, P., J. Van Damme, and G. Opdenakker. 1993. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun. 192:1175.
59. Singer, I. I., D. W. Kawka, E. K. Bayne, S. A. Donatelli, J. R. Weidner, H. R. Williams, J. M. Ayala, R. A. Mumford, M. W. Lark, T. T. Glant, et. al. 1995. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95:2178.
60. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, K. L. Neville, R. L. Yauch, and B. S Kim. 1997. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. J. Neurovirol. 3(Suppl. 1):S62.
61. Rivera, S., E. Tremblay, S. Timsit, O. Canals, Y. Ben-Ari, and M. Khrestchatisky. 1997. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J. Neurosci. 17:4223.
62. Lezin, A., S. Baurt, D. Smadja, H. Akaoka, O.Bourdonné, A. Perret-Liaudet, R. Cesaire, M. F. Belin, and P. Giraudon. Tissue inhibitor of metalloproteinases TIMP-3, matrix metalloproteinase-9, and neopterin in cerebrospinal fluid: preferential presence in HTLV-1-infected neurologic patients versus healthy virus carriers. AIDS Res. Hum. Retroviruses, In press.